Page last updated: 2024-09-02

tamibarotene and Cutaneous T-Cell Lymphoma

tamibarotene has been researched along with Cutaneous T-Cell Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Egusa, C; Kato, Y; Maeda, T; Tsuboi, R	1

Other Studies

1 other study(ies) available for tamibarotene and Cutaneous T-Cell Lymphoma

Article	Year
Combination of retinoid and histone deacetylase inhibitor produced an anti-tumor effect in cutaneous T-cell lymphoma by restoring tumor suppressor gene, retinoic acid receptorβ2, via histone acetylation. Journal of dermatological science, 2016, Volume: 81, Issue:1 Topics: Acetylation; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Benzoates; Cell Line, Tumor; Cell Proliferation; Female; Genes, Tumor Suppressor; Histone Deacetylase Inhibitors; Histones; Humans; Lymphoma, T-Cell, Cutaneous; Mice; Mice, Inbred NOD; Mice, SCID; Promoter Regions, Genetic; Pyridines; Receptors, Retinoic Acid; Retinoids; Skin Neoplasms; Tetrahydronaphthalenes; Xenograft Model Antitumor Assays	2016

Article

Year

Combination of retinoid and histone deacetylase inhibitor produced an anti-tumor effect in cutaneous T-cell lymphoma by restoring tumor suppressor gene, retinoic acid receptorβ2, via histone acetylation.

Journal of dermatological science, 2016, Volume: 81, Issue:1

Topics: Acetylation; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Benzoates; Cell Line, Tumor; Cell Proliferation; Female; Genes, Tumor Suppressor; Histone Deacetylase Inhibitors; Histones; Humans; Lymphoma, T-Cell, Cutaneous; Mice; Mice, Inbred NOD; Mice, SCID; Promoter Regions, Genetic; Pyridines; Receptors, Retinoic Acid; Retinoids; Skin Neoplasms; Tetrahydronaphthalenes; Xenograft Model Antitumor Assays

2016